
Added: July 8, 2008 | Time 02:39 | Views: 146
Thyroid cancer that has spread to distant sites has a poor prognosis, but an experimental drug that inhibits tumor blood vessel formation can slow disease progression in some patients, a research team led by investigators from The University of Texas M. D. Anderson Cancer Center reports in the July 3rd edition of The New England Journal of Medicine.
Please log in at the top of the page to post a comment!

By using this service, you accept our Terms of Service. Please read them. The health information on this site is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen.

© 2008 icyou, a product of Benefitfocus Media. All Rights Reserved. Terms Of Use | Privacy Policy
Comments
Post a Comment